Alzheimer’s Drugs Market Outlook 2025–2031: Strategic Moves by Novartis AG and Pfizer Inc | #alzheimer’s clinical trials # Alzheimer’s drug approvals # neurodegenerative disease drugs # Alzheimer’s monoclonal antibodies # Alzheimer’s symptomatic treatment